Crossmark

Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice

Published Online: 2020-05-12

Published Print: 2020-12

Authors

Adamowicz, Krzysztof https://orcid.org/0000-0003-4418-0560
Baczkowska-Waliszewska, Zuzanna
License Information

Text and Data Mining valid from 2020-05-12

Version of Record valid from 2020-05-12
More Information

Article History

Received: 5 December 2018

Accepted: 30 April 2020

First Online: 12 May 2020

Ethics approval and consent to participate

: Bioethical Commission at the District Chamber of Physicians in Gdansk.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current